Celldex Therapeutics (CLDX) Given Daily Coverage Optimism Score of 0.08

HC Wainwright reissued a "buy" rating and issued a $10.00 target price on shares of Celldex Therapeutics in a research note on Tuesday, August 1st. Finally, BidaskClub downgraded shares of Celldex Therapeutics from a "sell" rating to a "strong sell" rating in a research note on Monday, July 24th. Zacks Investment Research downgraded shares of Celldex Therapeutics from a "buy" rating to a "hold" rating in a research note on Tuesday, June 27th. Finally, Cowen and Company restated a buy rating on shares of Celldex Therapeutics in a research report on Tuesday, June 6th. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The stock has a consensus rating of "Hold" and a consensus price target of $7.32.

To shift focus on performance of the Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. (CLDX) has the market capitalization of $354.19 Million. Overall, 2.72 Million shares exchanged hands versus its average trading volume of 1.45 Million shares. For CLDX, the company now has $66.16 Million of cash on the books. The company has a 50-day moving average of $2.41 and a 200 day moving average of $2.88. The 5 months chart pattern indicates high risk for the $322.14 million company. Also published the news titled: "Celldex Therapeutics' (CLDX) CEO Anthony Marucci on Q2 2017 Results - Earnings ..." on August 09, 2017. The biopharmaceutical company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.05. Next quarter's EPS is forecasted to be $-0.28 with next year's EPS projected to be $-1.00. Return on Equity (ROE) stands at -51.9% and Return on Investment (ROI) of -50.1 percent. The business's revenue was up 175.5% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.32) earnings per share. Celldex Therapeutics, Inc. (NASDAQ:CLDX) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges.

A number of institutional investors have recently added to or reduced their stakes in CLDX. Morgan Stanley's holdings in Celldex Therapeutics were worth $1,835,000 as of its most recent SEC filing. Meditor Group Ltd now owns 5,800,000 shares of the biopharmaceutical company's stock worth $14,326,000 after purchasing an additional 1,654,100 shares during the period. Bank of New York Mellon Corp increased its holdings in Celldex Therapeutics by 1.1% during the 1st quarter. Canada Pension Plan Investment Board boosted its position in shares of Celldex Therapeutics by 106.7% during the 1st quarter. (NASDAQ CLDX) traded up 0.201% during mid-day trading on Wednesday, hitting $2.495. Teachers Advisors LLC boosted its position in shares of Celldex Therapeutics by 0.9% during the 4th quarter. Renaissance Technologies LLC now owns 1,707,927 shares of the biopharmaceutical company's stock worth $6,166,000 after purchasing an additional 508,217 shares during the period. Vanguard Group Inc. now owns 9,774,858 shares of the biopharmaceutical company's stock valued at $24,143,000 after buying an additional 708,095 shares during the last quarter.

Biglari Holdings a holding company owning subsidiaries engaged in various business activities, including media, property and casualty insurance, and restaurants The Company's divisions include Restaurant Operations, First Guard, Maxim, Other and Corporate.

Celldex Therapeutics, Inc. (CLDX)'s RSI (Relative Strength Index) is 59.10. The Company is using the technologies to develop targeted immunotherapeutics consisting of protein-based molecules, such as vaccines, antibodies and antibody-drug conjugates that are used to treat specific types of cancer or other diseases. The Company's lead drug Rintega is a therapeutic vaccine, which is meant for the treatment of glioblastoma patients.

To view ValuEngine's full report, visit ValuEngine's official website.

Like this


13 September 2017
Romania is a member of the World Tourism Organization's executive council
Also elected were Lithuania (27 votes), Russian Federation (22), Romania (22) and Azerbaijan (20). Several countries have competed to get one of the five places in the executive council.

13 September 2017
Hot Stock Overview: Chubb Limited (CB)
CB is now undervalued by -7.16% relative to the average 1-year price target of $157.13 taken from a group of Wall Street Analysts. Chubb Limited (CB ) belonging to the Financial Services sector has surged 3.57% and closed its last trading session at $145.88.

13 September 2017
Clear Channel Outdoor Holdings, (NYSE:CCO) Stock Traded Under Its 50 Day Average
The company was downgraded on Friday, May 13 by Evercore. (NYSE:CCO) earned "Neutral" rating by Wedbush on Friday, February 24. It has outperformed by 47.36% the S&P500. (NYSE:CCO). 1,118 were reported by Pub Employees Retirement Association Of Colorado.

13 September 2017
Allergan partners with Indian tribe to protect drug patents
For the tribe, it's a new revenue stream that could lead to more down the road. "We want to be self-reliant". The company is facing challenges to the Restasis patents in front of that board and in federal court.

13 September 2017
Sandy Spring Bank Sells 17672 Shares of QUALCOMM Incorporated (NASDAQ:QCOM)
The company has market cap of $1.31 billion. (NASDAQ: QCOM ) has "Hold" rating given on Monday, August 21 by BMO Capital Markets. The company was maintained on Tuesday, March 15 by Canaccord Genuity. (NASDAQ:QCOM) on Wednesday, October 12 with "Buy" rating.

13 September 2017
Sterling Construction Company Inc (NASDAQ:STRL) Shares Bought by Vanguard Group Inc
The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website . TRADEMARK VIOLATION WARNING: This piece was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal.

13 September 2017
Exelon Corporation (EXC) PT Raised to $40.00 at Morgan Stanley
Finally, State of Tennessee Treasury Department boosted its holdings in shares of Exelon Corporation by 385.6% in the 1st quarter. Investors might also notice that two months ago the Buy recommendations (0) were less than Sell recommendations (0).

13 September 2017
Building collapses during 'monstrous' fire which spread into Sainsbury's
Essex Fire Service said the fire was now out after previously saying they had "surrounded" it and had it "under control". Lee Hayes, from Kent, saw smoke billowing into the sky and told Essex Live: 'We watched the smoke rise but we're in Kent.

13 September 2017
Pioneer Natural Resources Company (PXD) Shares Sold by Commerzbank Aktiengesellschaft FI
Moreover, Waters Parkerson & Limited Liability Com has 1.34% invested in Pioneer Natural Resources (NYSE:PXD) for 73,747 shares. Great Lakes Advisors Ltd Liability stated it has 0.03% of its portfolio in Pioneer Natural Resources (NYSE:PXD). (NASDAQ:TRNS).

13 September 2017
Bank Nova Scotia Halifax Pfd 3 (BNS) Hits 52-Week High
It also upped Iamgold Corp (NYSE:IAG) stake by 796,368 shares and now owns 919,432 shares. (NYSE:RAI) or 14,141 shares. Shares for $25.14 million were sold by Sandberg Sheryl on Tuesday, June 6. 434,523 shares of the company traded hands.